Apogee Therapeutics
APGE
#4213
Rank
NZ$3.35 B
Marketcap
$57.75
Share price
-7.63%
Change (1 day)
-41.00%
Change (1 year)

Apogee Therapeutics (APGE) - Cash on Hand

Cash on Hand as of December 2024 : NZ$0.93 Billion

According to Apogee Therapeutics's latest financial reports the company has NZ$0.93 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Apogee Therapeutics - Cash on Hand chart (from 2022 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.92 B47.63%
2023-12-31NZ$0.62 B161.39%
2022-12-31NZ$0.23 B